Video

Diana Gordon on Caring for Children With Cancer

Author(s):

Diana Gordon, RN, MSN, CPNP, CPON

Gordon was one of our 2016 Extraordinary Healer Award finalists.

Diana Gordon, RN, MSN, CPNP, CPON, Division of Pediatric Hematology Oncology, University of North Carolina-Chapel Hill, and one of our 2016 Extraordinary Healer Award finalists, discusses her passion for caring for children with cancer.

When Gordon began working with hospitalized children on the general pediatric floor early in her nursing career, she found it was the children with chronic illnesses that drew her to them, including cancer because of the ongoing therapy it required. She also found it was important to include the whole family, establishing a relationship that would give the family a sense of security.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Waldenstrom macroglobulinemia is often slow growing, with high survival but lower quality of life over time, explained researcher Alisha Kimble.
Image of woman.
Image of two doctors and text.
Combining JNJ-1900 with Keytruda may improve distant control of lung cancer, explained by Dr. Jared Weiss.
image of serzan.
Dr. Breelyn Wilky explains that personalized treatments are helping improve outcomes for patients with gastrointestinal stromal tumors.
Image of two doctors with text.
Image of doctors with text.
Treatment with zanzalintinib plus Opdivo and Opdualag is an option worth exploring in patients with previously untreated clear cell renal cell carcinoma
Image of two doctors and text.
Related Content
DPOAE testing showed no hearing loss in children with retinoblastoma treated with intra-arterial paraplatin: © stock.adobe.com.
May 22nd 2025

Intra-Arterial Paraplatin Shows No Hearing Loss in Retinoblastoma

Spencer Feldman
DPOAE testing showed no hearing loss in children with retinoblastoma treated with intra-arterial paraplatin, suggesting preserved cochlear function.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
CURE spoke with Dr. Michael K. Wong and Dr. Diwakar Davar about the use of ctDNA for patients with melanoma, and where the field may be headed.
April 11th 2025

What Role May ctDNA Have in Melanoma Management?

Dr. Michael K. Wong
CURE spoke with Dr. Michael K. Wong and Dr. Diwakar Davar about the use of ctDNA for patients with melanoma, and where the field may be headed.
Guidelines for Childhood Neuroblastoma, FDA Decisions and More
February 12th 2024

Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Alex Biese Brielle Benyon
Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews
Woman with young cancer patient.
April 2nd 2025

Addressing Gaps, Challenges and Disparities in AYA Cancer Care

Ryan Scott
Adolescent and young adult patients with cancer face delayed diagnoses, financial hardships and gaps in specialized care, creating a need for tailored support.
Childhood cancer survivors are at risk of experiencing onset of aging-related disease 17.7 years sooner than the general population: © Konstantin Yuganov - stock.adobe.com
March 28th 2025

Childhood Cancer Survivors May Experience Sooner Aging-Related Disease

Alex Biese
Researchers have found childhood cancer survivors are at risk of experiencing onset of aging-related disease 17.7 years sooner than the general population.